DOCS
Get informed when a big investor buys or sells
+ FollowUndervalued by 20.4% based on the discounted cash flow analysis.
| Market cap | $5.95 Billion |
|---|---|
| Enterprise Value | $5.80 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.05 |
| Beta | 1.22 |
| Outstanding Shares | 182,569,000 |
| P/E Ratio | 37.52 |
|---|---|
| PEG | -68.97 |
| Price to Sales | 11.13 |
| Price to Book Ratio | 6.68 |
| Enterprise Value to Revenue | 8.84 |
| Enterprise Value to EBIT | 28.87 |
| Enterprise Value to Net Income | 34 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.13 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 169.79% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 1.06%▼ 68.64% |
|---|---|
| Total Invested | $55.07M▼ 97.94% |
| Investors Holding | 32▼ 347.00% |
No data
Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include over 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinica...